Evidence for using alendronate to treat adult avascular necrosis of the femoral head: A systematic review

Medical Science Monitor

Volumn 20, Issue , 2014, Pages 2439-2447

  Luo, Ru Bin ^a   Lin, Tiao ^a   Zhong, Hui Ming ^a   Yan, Shi Gui ^a   Wang, Jian An ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Alendronate; Femur Head Necrosis; Review Literature as Topic

Indexed keywords

ALENDRONIC ACID; CALCIUM; COLECALCIFEROL; PLACEBO;

ABDOMINAL DISCOMFORT; ADULT; ALLERGY; AVASCULAR NECROSIS; BONE RADIOGRAPHY; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DYSPEPSIA; EVIDENCE BASED MEDICINE; FEMUR HEAD NECROSIS; FOLLOW UP; HARRIS HIP SCORE; HEADACHE; HIP PAIN; HUMAN; JOINT FUNCTION; LONG TERM CARE; MEDICAL LITERATURE; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PUBLICATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TOTAL HIP PROSTHESIS; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ANALOG SCALE; ADOLESCENT; AGED; DEMOGRAPHY; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; TIME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALENDRONATE; DEMOGRAPHY; FEMALE; FEMUR HEAD NECROSIS; HUMANS; MALE; MIDDLE AGED; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84912132424     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.891123     Document Type: Review

References (41)

1. Petrigliano FA, Lieberman JR: Osteonecrosis of the hip: novel approaches to evaluation and treatment. Clin Orthop Relat Res, 2007; 465: 53–62
2. Lavernia CJ, Sierra RJ, Grieco FR: Osteonecrosis of the femoral head. J Am Acad Orthop Surg, 1999; 7(4): 250–61
3. Seamon J, Keller T, Saleh J, Cui Q: The pathogenesis of nontraumatic osteo-necrosis. Arthritis, 2012; 2012: 601763
4. Jergesen HE, Khan AS: The natural history of untreated asymptomatic hips in patients who have non-traumatic osteonecrosis. J Bone Joint Surg Am, 1997; 79(3): 359–63
5. Mont MA, Seyler TM, Plate JF et al: Uncemented total hip arthroplasty in young adults with osteonecrosis of the femoral head: a comparative study. J Bone Joint Surg Am, 2006; 88(Suppl.3): 104–9
6. Mont MA, Seyler TM, Marker DR et al: Use of metal-on-metal total hip resurfacing for the treatment of osteonecrosis of the femoral head. J Bone Joint Surg Am, 2006; 88(Suppl.3): 90–97
7. Marker DR, Seyler TM, McGrath MS et al: Treatment of early stage osteone-crosis of the femoral head. J Bone Joint Surg Am, 2008; 90(Suppl.4): 175–87
8. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF: Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors afecting survivorship of acetabular and femoral components. J Bone Joint Surg Am, 2002; 84-A(2): 171–77
9. Dorr LD, Takei GK, Conaty JP: Total hip arthroplasties in patients less than forty-fve years old. J Bone Joint Surg Am, 1983; 65(4): 474–79
10. Young ML, Little DG, Kim HK: Evidence for using bisphosphonate to treat Legg-Calve-Perthes disease. Clin Orthop Relat Res, 2012; 470(9): 2462–75
11. Cardozo JB, Andrade DM, Santiago MB: The use of bisphosphonate in the treatment of avascular necrosis: a systematic review. Clin Rheumatol, 2008; 27(6): 685–88
12. Chen CH, Chang JK, Lai KA et al: Alendronate in the prevention of collapse of the femoral head in nontraumatic osteonecrosis: a two-year multicenter, prospective, randomized, double-blind, placebo-controlled study. Arthritis Rheum, 2012; 64(5): 1572–78
13. Agarwala S, Shah SB: Ten-year follow-up of avascular necrosis of femoral head treated with alendronate for 3 years. J Arthroplasty, 2011; 26(7): 1128–34
14. Agarwala S, Shah S, Joshi VR: The use of alendronate in the treatment of avascular necrosis of the femoral head: follow-up to eight years. J Bone Joint Surg Br, 2009; 91(8): 1013–18
15. Nishii T, Sugano N, Miki H et al: Does alendronate prevent collapse in os-teonecrosis of the femoral head? Clin Orthop Relat Res, 2006; 443: 273–79
16. Lai KA, Shen WJ, Yang CY et al: The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis. A randomized clinical study. J Bone Joint Surg Am, 2005; 87(10): 2155–59
17. Agarwala S, Jain D, Joshi VR, Sule A: Efficacy of alendronate, a bisphospho-nate, in the treatment of AVN of the hip. A prospective open-label study. Rheumatology, 2005; 44(3): 352–59
18. Agarwala S, Sule A, Pai BU, Joshi VR: Alendronate in the treatment of avas-cular necrosis of the hip. Rheumatology, 2002; 41(3): 346–47
19. Shu-Qing C, You-Jin C, Hou-Ming Z, Jian Q: Clinical efficacy of alendronate treatment of early-stage adult nontraumatic avascular necrosis of femoral head. Chinese Journal of Geriatrics, 2011; 30(8): 661–63
20. Phillips Bob DS, Chris Ball, Badenoch Doug et al: Oxford Centre for Evidence-based Medicine – Levels of Evidence (March 2009).
21. Mont MA, Marulanda GA, Jones LC et al: Systematic analysis of classifca-tion systems for osteonecrosis of the femoral head. J Bone Joint Surg Am, 2006; 88(Suppl.3): 16–26
22. Rajagopal M, Balch Samora J, Ellis TJ: Efficacy of core decompression as treatment for osteonecrosis of the hip: a systematic review. Hip Int, 2012; 22(5): 489–93
23. Shannon BD, Trousdale RT: Femoral osteotomies for avascular necrosis of the femoral head. Clin Orthop Relat Res, 2004; (418): 34–40
24. Ali SA, Christy JM, Griesser MJ et al: Treatment of avascular necrosis of the femoral head utilising free vascularised fbular graft: a systematic review. Hip Int, 2014; 24(1): 5–13
25. Fang T, Zhang EW, Sailes FC et al: Vascularized fbular grafts in patients with avascular necrosis of femoral head: a systematic review and meta-analysis. Arch Orthop Trauma Surg, 2013; 133(1): 1–10
26. Varitimidis SE, Dimitroulias AP, Karachalios TS et al: Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years. Acta Orthop, 2009; 80(1): 20–25
27. Chan KL, Mok CC: Glucocorticoid-induced avascular bone necrosis: diagnosis and management. Open Orthop J, 2012; 6: 449–57
28. Koo KH, Kim R, Kim YS et al: Risk period for developing osteonecrosis of the femoral head in patients on steroid treatment. Clinical rheumatology, 2002; 21(4): 299–303
29. Vail TP, Urbaniak JR: Donor-site morbidity with use of vascularized autogenous fbular grafts. J Bone Joint Surg Am, 1996; 78(2): 204–11
30. Hungerford DS: Treatment of osteonecrosis of the femoral head: everything’s new. J Arthroplasty, 2007; 22(4 Suppl.1): 91–94
31. Pritchett JW: Statin therapy decreases the risk of osteonecrosis in patients receiving steroids. Clin Orthop Relat Res, 2001; (386): 173–78
32. Wang GJ, Cui Q, Balian G: The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res, 2000; (370): 295–310
33. Wang Y, Yin L, Li Y et al: Preventive efects of puerarin on alcohol-induced osteonecrosis. Clin Orthop Relat Res, 2008; 466(5): 1059–67
34. Glueck CJ, Freiberg RA, Sieve L, Wang P: Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res, 2005; (435): 164–70
35. Jager M, Tillmann FP, Thornhill TS et al: Rationale for prostaglandin I2 in bone marrow oedema – from theory to application. Arthritis Res Ther, 2008; 10(5): R120
36. Disch AC, Matziolis G, Perka C: The management of necrosis-associated and idiopathic bone-marrow oedema of the proximal femur by intravenous ilo-prost. J Bone Joint Surg Br, 2005; 87(4): 560–64
37. Wang GJ, Moga DB, Richemer WG et al: Cortisone induced bone changes and its response to lipid clearing agents. Clin Orthop Relat Res, 1978; (130): 81–85
38. Wang GJ, Sweet DE, Reger SI, Thompson RC: Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J Bone Joint Surg Am, 1977; 59(6): 729–35
39. Peled E, Bejar J, Zinman C et al: Alendronate preserves femoral head shape and height/length ratios in an experimental rat model: A computer-assisted analysis. Indian J Orthop, 2009; 43(1): 22–26
40. Peled E, Bejar J, Zinman C et al: Prevention of distortion of vascular deprivation-induced osteonecrosis of the rat femoral head by treatment with alendronate. Arch Orthop Trauma Surg, 2009; 129(2): 275–79
41. Hofstaetter JG, Wang J, Yan J, Glimcher MJ: The effects of alendronate in the treatment of experimental osteonecrosis of the hip in adult rabbits. Osteoarthritis Cartilage, 2009; 17(3): 362–70